<?xml version="1.0" encoding="UTF-8"?>
<p id="Par25">The final predictive model for the ability of the initial cyclosporine trough blood concentration after HSCT to be in the therapeutic range, after a tenfold cross-validation, presented good validation characteristics with an AUC-ROC of 0.89 ± 0.02 (see Fig. 
 <xref rid="Fig3" ref-type="fig">3</xref>), 18.9 ± 2.6% of incorrectly classified patients, a positive predictive value of 85.9 ± 3.4% and a negative predictive value of 74.2 ± 5.1%. 
</p>
